Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.

Post-translational modifications such as ubiquitination, phosphorylation, and acetylation play important roles in the regulation of Smad-mediated functions. Here, we demonstrate that Smad4 is covalently modified by SUMO-1, which was characterized recently as a key modulator of many transcription factors. Sumoylation of Smad4 mainly occurs at lysine 159, located in the linker region, and facilitates Smad-dependent transcriptional activation. Furthermore, we show that the PIAS family proteins, PIAS1 and PIASx beta, function as E3 ligase factors for Smad4. Intriguingly, sumoylation of Smad4 was strongly enhanced by TGF-beta-induced activation of the p38 MAP kinase pathway but not the Smad pathway. Activation of p38 not only stabilized PIASx beta protein but also enhanced PIASx beta gene expression, suggesting that PIAS-mediated sumoylation of Smad4 is regulated by the p38 MAP kinase pathway. These findings illustrate a novel regulatory mechanism by which Smad-dependent transcriptional activation cooperatively modulates Smad proteins through receptor-mediated phosphorylation and sumoylation.

Pubmed ID: 14514699 RIS Download

Mesh terms: Animals | COS Cells | DNA-Binding Proteins | Humans | MAP Kinase Signaling System | Mitogen-Activated Protein Kinases | Protein Inhibitors of Activated STAT | Protein Processing, Post-Translational | Receptor Cross-Talk | SUMO-1 Protein | Smad4 Protein | Trans-Activators | Transcription Factors | Transcription, Genetic | Transfection | Transforming Growth Factor beta | Ubiquitin-Protein Ligases | p38 Mitogen-Activated Protein Kinases

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.